This site uses cookies to improve your browsing experience and to allow us to analyze our traffic. For more information on the cookies we use and our privacy policy, click here.
Accept
See how COVID-19 affects kidney health, receive guidance on how to clean our products and our response to the pandemic.
For interventional cardiologists who want to manage contrast delivery and minimize risk of contrast-induced acute kidney injury (CI-AKI), ACIST CVi™ delivers the power to control and protect.
ACIST HDi® provides you the power to see with clarity, for optimizing PCI through intravascular imaging.
ACIST RXi® and ACIST RXi® Mini™ simplify physiological assessment of complex coronary artery disease. The Navvus® MicroCatheters give you the freedom to quickly and easily assess FFR.
An expert physician’s perspective on the ACIST CVi™ Contrast Delivery System:
Dr. Mark Rothenberg, MD, FACC
Minimizing the contrast exposure and possibly using the least nephrotoxic contrast are critical in angiography and percutaneous coronary intervention (PCI) in patients with pre-existing chronic kidney disease (CKD).
Dr. Arnold Seto
Cases performed with CVi
Experience three imaging modes with HDi
Use your guidewire of choice with RXi and the Navvus® MicroCatheters.
ACIST provides a variety of clinical education materials, including clinical research, continuing education webinars, videos, instructional materials and more.
* economic value based on the reduced cost of QFR compared to conventional FFR and the respective cost of administration of hyperemic agent (adenosine) and additional invasive procedural resources
** Reduced side effect profile when compared to FFR with adenosine induced hyperemia
ACIST Medical Systems, Inc. is in a distribution partnership with Medis Medical Imaging to comarket QFR® in North America.
© 2023 ACIST Medical Systems. All rights reserved.
